Search

everythinglearnresearchcommunity

for

Search:↓

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The healthcare for transgender veterans could be better with a more unified team approach.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair transplants are effective for some women and many male-to-female transgender patients if done carefully by an experienced team.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Finasteride and dutasteride do not significantly change beard thickness in men.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.